Crossref journal-article
Springer Science and Business Media LLC
Nature (297)
Bibliography

Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399(6733), 271–275.

Authors 10
  1. Patrick H. Maxwell (first)
  2. Michael S. Wiesener (additional)
  3. Gin-Wen Chang (additional)
  4. Steven C. Clifford (additional)
  5. Emma C. Vaux (additional)
  6. Matthew E. Cockman (additional)
  7. Charles C. Wykoff (additional)
  8. Christopher W. Pugh (additional)
  9. Eamonn R. Maher (additional)
  10. Peter J. Ratcliffe (additional)
References 30 Referenced 4,165
  1. Wang, G. L., Jiang, B.-H., Rue, E. A. & Semenza, G. L. Hypoxia-inducible factor I is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2tension. Proc. Natl Acad. Sci. USA 92, 5510–5514 (1995). (10.1073/pnas.92.12.5510) / Proc. Natl Acad. Sci. USA by GL Wang (1995)
  2. Bunn, H. F. & Poyton, R. O. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76, 839– 885 (1996). (10.1152/physrev.1996.76.3.839) / Physiol. Rev. by HF Bunn (1996)
  3. Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485 –90 (1998). (10.1038/28867) / Nature by P Carmeliet (1998)
  4. An, W. G. et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1α. Nature 392, 405–408 (1998). (10.1038/32925) / Nature by WG An (1998)
  5. Huang, L. E., Gu, J., Schau, M. & Bunn, H. F. Regulation of hypoxia-inducible factor 1α is mediated by an oxygen-dependent domain via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 95, 7987–7992 ( 1998). (10.1073/pnas.95.14.7987) / Proc. Natl Acad. Sci. USA by LE Huang (1998)
  6. Goldberg, M. A., Dunning, S. P. & Bunn, H. F. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242, 1412–1415 (1988). (10.1126/science.2849206) / Science by MA Goldberg (1988)
  7. Wang, G. L. & Semenza, G. L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82 , 3610–3615 (1993). (10.1182/blood.V82.12.3610.3610) / Blood by GL Wang (1993)
  8. Warburg, O. The Metabolism of Tumours (Arnold Constable, London, ( 1930). / The Metabolism of Tumours by O Warburg (1930)
  9. Hanahan, D. & Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353–364 (1996). (10.1016/S0092-8674(00)80108-7) / Cell by D Hanahan (1996)
  10. Shweiki, D., Itin, A., Soffer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992). (10.1038/359843a0) / Nature by D Shweiki (1992)
  11. Kaelin, W. G. & Maher, E. R. The VHL tumour-suppressor gene paradigm. Trends Genet. 14, 423– 426 (1998). (10.1016/S0168-9525(98)01558-3) / Trends Genet. by WG Kaelin (1998)
  12. Gnarra, J. R. et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl Acad. Sci. USA 93, 10589– 10594 (1996). (10.1073/pnas.93.20.10589) / Proc. Natl Acad. Sci. USA by JR Gnarra (1996)
  13. Iliopoulos, O., Levy, A. P., Jiang, C., Kaelin, W. G. J & Goldberg, M. A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl Acad. Sci. USA 93, 10595–10599 (1996). (10.1073/pnas.93.20.10595) / Proc. Natl Acad. Sci. USA by O Iliopoulos (1996)
  14. Dang, C. V. & Semenza, G. L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 24, 68– 72 (1999). (10.1016/S0968-0004(98)01344-9) / Trends Biochem. Sci. by CV Dang (1999)
  15. Huang, L. E., Arany, Z., Livingston, D. M. & Bunn, H. F. Activation of hypoxia-inducible transcription factor depends primarily on redox-sensitive stabilization of its α subunit. J. Biol. Chem. 271, 32253–32259 ( 1996). (10.1074/jbc.271.50.32253) / J. Biol. Chem. by LE Huang (1996)
  16. Wiesener, M. S. et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood 92, 2260–2268 ( 1998). (10.1182/blood.V92.7.2260) / Blood by MS Wiesener (1998)
  17. Iliopoulos, O., Kibel, A., Gray, S. & Kaelin, W. G. J Tumour supression by the human von Hippel-Lindau gene product. Nature Med. 1, 822–826 (1995). (10.1038/nm0895-822) / Nature Med. by O Iliopoulos (1995)
  18. Salceda, S. & Caro, J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. J. Biol. Chem. 272, 22642– 22647 (1997). (10.1074/jbc.272.36.22642) / J. Biol. Chem. by S Salceda (1997)
  19. Pause, A. et al. the von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc. Natl Acad. Sci. USA 94, 2156– 2161 (1997). (10.1073/pnas.94.6.2156) / Proc. Natl Acad. Sci. USA by A Pause (1997)
  20. Lonergan, K. M. et al. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell Biol. 18, 732– 741 (1998). (10.1128/MCB.18.2.732) / Mol. Cell Biol. by KM Lonergan (1998)
  21. Maxwell, P. H. et al. Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94, 8104–8109 (1997). (10.1073/pnas.94.15.8104) / Proc. Natl Acad. Sci. USA by PH Maxwell (1997)
  22. Zelzer, E. et al. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J. 17, 5083 –5094 (1998). (10.1093/emboj/17.17.5085) / EMBO J. by E Zelzer (1998)
  23. Duan, D. R. et al. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 269, 1402– 1406 (1995). (10.1126/science.7660122) / Science by DR Duan (1995)
  24. Ohh, M. et al. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Mol. Cell 1, 959–968 ( 1998). (10.1016/S1097-2765(00)80096-9) / Mol. Cell by M Ohh (1998)
  25. Wood, S. M. et al. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 α-subunit (HIF-1α). J. Biol. Chem. 273, 8360–8368 (1998). (10.1074/jbc.273.14.8360) / J. Biol. Chem. by SM Wood (1998)
  26. Fandrey, J., Frede, S. & Jelkmann, W. Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem. J. 303, 507– 510 (1994). (10.1042/bj3030507) / Biochem. J. by J Fandrey (1994)
  27. Iwai, K. et al. Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein 2: implications for degradation of oxidized proteins. Proc. Natl Acad. Sci. USA 95, 4924– 4928 (1998). (10.1073/pnas.95.9.4924) / Proc. Natl Acad. Sci. USA by K Iwai (1998)
  28. Ho, V. T. & Bunn, H. F. Effects of transition metals on the expression of the erythropoietin gene: further evidence that the oxygen sensor is a heme protein. Biochem. Biophys. Res. Commun. 223, 175–180 (1996). (10.1006/bbrc.1996.0865) / Biochem. Biophys. Res. Commun. by VT Ho (1996)
  29. Chandel, N. S. et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl Acad. Sci. USA 95, 11715–11720 (1998). (10.1073/pnas.95.20.11715) / Proc. Natl Acad. Sci. USA by NS Chandel (1998)
  30. Gnarra, J. R. et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genet. 7, 85– 90 (1994). (10.1038/ng0594-85) / Nature Genet. by JR Gnarra (1994)
Dates
Type When
Created 23 years ago (July 26, 2002, 4:39 a.m.)
Deposited 3 years, 8 months ago (Dec. 1, 2021, 7:12 p.m.)
Indexed 3 hours, 6 minutes ago (Aug. 21, 2025, 1:14 p.m.)
Issued 26 years, 3 months ago (May 1, 1999)
Published 26 years, 3 months ago (May 1, 1999)
Published Print 26 years, 3 months ago (May 1, 1999)
Funders 0

None

@article{Maxwell_1999, title={The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis}, volume={399}, ISSN={1476-4687}, url={http://dx.doi.org/10.1038/20459}, DOI={10.1038/20459}, number={6733}, journal={Nature}, publisher={Springer Science and Business Media LLC}, author={Maxwell, Patrick H. and Wiesener, Michael S. and Chang, Gin-Wen and Clifford, Steven C. and Vaux, Emma C. and Cockman, Matthew E. and Wykoff, Charles C. and Pugh, Christopher W. and Maher, Eamonn R. and Ratcliffe, Peter J.}, year={1999}, month=may, pages={271–275} }